ASCO 2015 - Prostate & Bladder Cancers

ASCO 2015 - Prostate & Bladder Cancers

Tom Keane, MBBCh, FRCSI, FACS discusses the following abstracts from ASCO 2015:

  • Phase III SYNERGY trial: Docetaxel +/- custirsen and overall survival in patients with metastatic castration-resistant prostate cancer and poor prognosis
  • First-line randomized phase II study of gemcitabine/cisplatin plus apatorsen or placebo in patients with advanced bladder cancer: The International Borealis-1 trial

Thomas E. Keane, MBBCh, FRCSI, FACS
Professor and Chairman of the Department of Urology
Medical University of South Carolina, Charleston, SC USA


Thomas E. Keane, MBBCh, FRCSI, FACS specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as principal investigator or coinvestigator on more than 20 major clinical and preclinical studies, funded by grants from the National Institutes of Health as well as industry-funded. Much of his work focuses on innovative concepts in translational research, including utilizing human tumor xenografts to investigate the efficacy of new therapies as they relate to GU malignancies with particular reference to cytotoxic agents, sphingolipids, and boron-containing compounds. He holds a U.S. patent for BNCT in prostate cancer and sphingolipid derivatives and their use.

Dr. Keane’s research has led to publication of more than 100 articles peer-reviewed in such journals as Cancer Research, The Journal of Urology, Urologic Oncology, and the Journal of Clinical Investigation. He provides editorial services to publications ranging from Urology to the International Journal of Cancer and is coeditor of the text Glenn’s Urologic Surgery, 6th, 7th, and 8th Edition. He is an accomplished speaker, having delivered many presentations to professional societies and symposia throughout the United States and abroad.


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.